Who owns OLEMA PHARMACEUTICALS INC?
- Ticker: OLMA
- CUSIP Number: 68062p106
Tip: Access positions for across all investors
Analyze quarterly positions in Olema Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv

Top investors of Olema Pharmaceuticals stock
Who bought or sold OLEMA PHARMACEUTICALS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | ||
---|---|---|---|---|---|---|
BVF | 6.7M | $320M | 100% | Dec 2020 | ||
Logos Global Management | 3.7M | $180M | 100% | Dec 2020 | ||
Henderson Group | 3.6M | $161M | 100% | Dec 2020 | ||
Cormorant Asset Management | 3.2M | $148M | 100% | Dec 2020 | ||
RA Capital Management | 2.2M | $103M | 100% | Dec 2020 | ||
Wellington Management Company | 2.1M | $96M | 100% | Dec 2020 | ||
VR Adviser | 1.5M | $74M | 100% | Dec 2020 | ||
Citadel Advisors | 1.4M | $69M | 100% | Dec 2020 | ||
Vivo Capital | 1.2M | $60M | 100% | Dec 2020 | ||
venBio Select Advisor | 877k | $36M | 100% | Dec 2020 | ||
Foresite Capital Management IV | 818k | $39M | 100% | Dec 2020 | ||
Setup an alertWant to be notified whenever an investor makes a significant change to their holdings of Olema Pharmaceuticals? |
||||||
Vanguard Group | 804k | $38M | 100% | Dec 2020 | ||
Deerfield Management Company | 696k | $34M | 100% | Dec 2020 | ||
BlackRock | 685k | $33M | 100% | Dec 2020 | ||
FMR | 655k | $32M | 100% | Dec 2020 | ||
OrbiMed Advisors | 651k | $31M | 100% | Dec 2020 | ||
Hillhouse Capital Advisors | 620k | $30M | 100% | Dec 2020 | ||
Invesco | 530k | $26M | 100% | Dec 2020 | ||
Franklin Resources | 370k | $18M | 100% | Dec 2020 | ||
Ameriprise Financial | 367k | $18M | 100% | Dec 2020 | ||
Driehaus Capital Management | 273k | $13M | 100% | Dec 2020 | ||
Avidity Partners Management | 270k | $13M | 100% | Dec 2020 | ||
Artal Group | 261k | $13M | 100% | Dec 2020 | ||
Federated Investors | 260k | $13M | 100% | Dec 2020 | ||
Tybourne Capital Management | 260k | $8.6M | 0% | Mar 2021 | ||
Arrowpoint Asset Management | 253k | $12M | 100% | Dec 2020 | ||
Pictet Asset Management | 161k | $7.7M | 100% | Dec 2020 | ||
Jpmorgan Chase & Co | 74k | $3.5M | 100% | Dec 2020 | ||
Goldman Sachs Group | 55k | $2.7M | 100% | Dec 2020 | ||
UBS Group | 53k | $2.6M | 100% | Dec 2020 | ||
Morgan Stanley | 46k | $2.2M | 100% | Dec 2020 | ||
Susquehanna International | 43k | $2.1M | 100% | Dec 2020 | ||
Geode Capital Management | 27k | $1.3M | 100% | Dec 2020 | ||
Atom Investors | 25k | $1.2M | 100% | Dec 2020 | ||
Parametric Portfolio Associates | 25k | $1.2M | 100% | Dec 2020 | ||
CalPERS | 24k | $1.2M | 100% | Dec 2020 | ||
Marshall Wace North America | 24k | $1.1M | 100% | Dec 2020 | ||
Hrt Financial | 23k | $1.1M | 100% | Dec 2020 | ||
ExodusPoint Capital Management | 22k | $1.0M | 100% | Dec 2020 | ||
Millennium Management | 19k | $892k | 100% | Dec 2020 | ||
Pinz Capital Management | 18k | $856k | 100% | Dec 2020 | ||
Sphera Funds Management | 15k | $731k | 100% | Dec 2020 | ||
Jefferies Group | 15k | $726k | 100% | Dec 2020 | ||
Northern Trust | 14k | $668k | 100% | Dec 2020 | ||
SG Americas Securities | 12k | $591k | 100% | Dec 2020 | ||
Tibra Equities Europe | 12k | $591k | 100% | Dec 2020 | ||
Mirabella Financial Services | 11k | $505k | 100% | Dec 2020 | ||
Qube Research & Technologies | 8.9k | $427k | 100% | Dec 2020 | ||
Citigroup | 6.9k | $332k | 100% | Dec 2020 | ||
Windsor Creek Advisors | 6.0k | $288k | 100% | Dec 2020 | ||
Maven Securities | 5.6k | $278k | 100% | Dec 2020 | ||
M^T Bank Corporation | 5.3k | $254k | 100% | Dec 2020 | ||
Athanor Capital | 5.2k | $250k | 100% | Dec 2020 | ||
Tower Research Capital | 570.00 | $27k | 100% | Dec 2020 | ||
Kinloch Capital | 500.00 | $24k | 100% | Dec 2020 | ||
Bank of America Corporation | 95.00 | $5.0k | 100% | Dec 2020 | ||
Private Capital Group | 31.00 | $1.0k | 100% | Mar 2021 | ||
Wells Fargo & Company | 30.00 | $999.999000 | 100% | Dec 2020 |